Zygelman M, Neukirch F, Mérillon J P, Dahan M, Trouillet J L, Juliard J M, Pansard Y, Gourgon R
Arch Mal Coeur Vaiss. 1984 Nov;77(12):1383-9.
The heart rate, cardiac output, coronary sinus blood flow, systolic and end diastolic left ventricular pressures, femoral arterial pressure and coronary oxygen arterio-venous difference were measured in 12 patients with stable coronary artery disease without cardiac failure on long-term betablocker therapy, before and 45 minutes after 2 or 3 mg sublingual molsidomine. The measurements were repeated in 8 patients during a cold pressor test. Under basal conditions, molsidomine decreased the systolic and end diastolic left ventricular pressures, mean femoral arterial pressure, cardiac output and double product. The coronary oxygen arterio-venous difference was unchanged. Coronary sinus flow and myocardial oxygen consumption decreased. In the 2 patients who were given 3 mg molsidomine, a progressive reduction in systolic left ventricular pressure to 70% or less than its initial value, necessitated immediate treatment with volume expanders. During the cold pressor test before molsidomine the systolic and end diastolic left ventricular pressures, mean femoral arterial pressure and the double product increased. Coronary sinus flow was unchanged overall: it decreased in 6 patients, increased in 2 patients and remained the same in 1 patient. Coronary resistance increased in 6 patients and decreased in only one patient. During the cold pressor test after molsidomine there was a significant reduction in the increase of systolic left ventricular pressure, mean femoral artery pressure and double product. Coronary sinus blood flow increased in 5 patients and decreased in only one case. Coronary resistance decreased in half the cases.(ABSTRACT TRUNCATED AT 250 WORDS)
对12例长期接受β受体阻滞剂治疗、无心力衰竭的稳定型冠状动脉疾病患者,在舌下含服2或3毫克吗多明前及用药后45分钟,测量其心率、心输出量、冠状窦血流量、左心室收缩压和舒张末期压力、股动脉压以及冠状动脉血氧动静脉差。在8例患者进行冷加压试验期间重复上述测量。在基础条件下,吗多明降低了左心室收缩压和舒张末期压力、平均股动脉压、心输出量和双乘积。冠状动脉血氧动静脉差未改变。冠状窦血流量和心肌耗氧量降低。在给予3毫克吗多明的2例患者中,左心室收缩压逐渐降至初始值的70%或更低,因此需要立即用扩容剂治疗。在给予吗多明前的冷加压试验期间,左心室收缩压和舒张末期压力、平均股动脉压和双乘积升高。冠状窦血流量总体未改变:6例患者降低,2例患者升高,1例患者保持不变。6例患者冠状动脉阻力增加,仅1例患者降低。在给予吗多明后的冷加压试验期间,左心室收缩压、平均股动脉压和双乘积的升高显著降低。5例患者冠状窦血流量增加,仅1例降低。半数病例冠状动脉阻力降低。(摘要截短于250字)